A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

NCT06867094 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis Ulcerative

Interventions

DRUG: SAR441566
DRUG: SAR441566 matching Placebo

Sponsor

Sanofi